What does this video actually claim?
@kaid572 shared a one-month update on Wegovy (semaglutide), using hashtags like #childobesity and #obese while documenting her weight loss journey. The video positions itself as a progress report on GLP-1 treatment.
Without seeing the specific claims made in the video content, we can only evaluate the broader context she's presenting. The hashtag choices suggest she's framing this as obesity treatment, which matches Wegovy's FDA approval.
One month updates are common on social media, but they don't tell the full story of how these medications work over time.
How effective is Wegovy after one month?
One month is too early to judge Wegovy's full effectiveness. The STEP 1 trial (Wilding et al., NEJM, 2021) showed that meaningful weight loss typically happens over months, not weeks.
At week 4 in clinical trials, patients on 2.4mg semaglutide saw modest weight reduction compared to the 14.9% average loss at 68 weeks. Most people start at 0.25mg and don't reach the full 2.4mg maintenance dose until week 16.
Early side effects like nausea and reduced appetite often drive initial weight changes, but these aren't predictive of long-term success. The real test comes after 3-6 months of treatment.
What about the childhood obesity hashtag?
The #childobesity hashtag is concerning if @kaid572 is an adult using Wegovy. Wegovy isn't approved for pediatric use in most cases, and mixing adult experiences with childhood obesity discussions can mislead parents.
The FDA approved Wegovy for adolescents 12 and older in December 2022, but only with specific BMI requirements and after lifestyle interventions failed. The dosing and monitoring requirements differ significantly from adult protocols.
Adult weight loss experiences don't translate to pediatric treatment. Parents shouldn't use TikTok testimonials to make decisions about their children's medical care.
What do the actual numbers show?
Real Wegovy data comes from multiple STEP trials, not one-month TikTok updates. The STEP 1 trial found 83.5% of patients lost at least 5% of body weight, while 66.1% lost at least 10%.
But these results took time. At week 20, average weight loss was around 10%. The full 14.9% average didn't appear until week 68. Side effects led to 7% of patients discontinuing treatment.
The STEP 2 trial in people with diabetes showed 9.6% weight loss at 68 weeks. Results vary significantly based on starting weight, adherence, and individual response to the medication.
What should you actually know?
Wegovy works, but not in the timeframe most TikTok videos suggest. One-month updates make for engaging content but poor medical evidence.
The medication costs around $1,300 monthly without insurance coverage. Many patients regain weight if they stop treatment, as shown in the STEP 1 extension study where participants regained two-thirds of lost weight after discontinuation.
Real success requires long-term commitment, lifestyle changes, and medical supervision. TikTok testimonials can't replace conversations with healthcare providers who understand your specific medical history and needs.